Cargando…

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant

Vaccines are proving to be highly effective in controlling hospitalization and deaths associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as shown by clinical trials and real-world evidence. However, a deadly second wave of coronavirus disease 2019 (COVID-19), inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mengxin, Liang, Ying, Yu, Dongsheng, Du, Bang, Cheng, Weyland, Li, Lifeng, Yu, Zhidan, Luo, Shuying, Zhang, Yaodong, Wang, Huanmin, Zhang, Xianwei, Zhang, Wancun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741840/ https://www.ncbi.nlm.nih.gov/pubmed/35002532 http://dx.doi.org/10.7150/ijbs.68973

Ejemplares similares

A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
por: Zhang, Mengxin, et al.
Publicado: (2022)

Plasma circulating cell‐free MYCN gene: A noninvasive and prominent recurrence monitoring indicator of neuroblastoma
por: Liang, Ying, et al.
Publicado: (2022)

Rapid electrochemical quantification of trace Hg(2+) using a hairpin DNA probe and quantum dot modified screen-printed gold electrodes
por: Zhang, Wancun, et al.
Publicado: (2022)

Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma
por: Du, Bang, et al.
Publicado: (2023)

An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward
por: Wi, Yu Mi, et al.
Publicado: (2022)

Changes of respiratory syncytial virus infection in children before and after the COVID-19 pandemic in Henan, China
por: Zhang, Mengxin, et al.
Publicado: (2022)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household
por: Yi, Seonju, et al.
Publicado: (2021)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
por: Farinholt, Timothy, et al.
Publicado: (2021)

Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections
por: Farinholt, Timothy, et al.
Publicado: (2021)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
por: Goto, Takeyuki, et al.
Publicado: (2022)

Epidemiological characteristics of Cytomegalovirus infection in children before and after the COVID-19 pandemic in Henan, China, 2016–2022
por: Zhang, Wancun, et al.
Publicado: (2023)

Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
por: Shastri, Jayanthi, et al.
Publicado: (2021)

Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy
por: Baj, Andreina, et al.
Publicado: (2021)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Clinical characteristics and severity of beta and delta variants of SARS-CoV-2 and the effect of vaccine on delta variants
por: Peng, Yahui, et al.
Publicado: (2022)

SARS-CoV-2 Delta Variant in Jingmen City, Hubei Province, China, 2021: Children Susceptible and Vaccination Breakthrough Infection
por: Li, Dan, et al.
Publicado: (2022)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
por: Yang, Yang, et al.
Publicado: (2022)

Changes of Mycoplasma pneumoniae infection in children before and after the COVID - 19 pandemic, Henan, China
por: Liang, Ying, et al.
Publicado: (2023)

Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
por: Collier, Ai-ris Y., et al.
Publicado: (2021)

An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam
por: Chau, Nguyen Van Vinh, et al.
Publicado: (2021)

Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
por: Stærke, Nina Breinholt, et al.
Publicado: (2022)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
por: Zou, Jing, et al.
Publicado: (2022)

Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
por: Christensen, Paul A., et al.
Publicado: (2022)

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
por: Chia, Po Ying, et al.
Publicado: (2022)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)

Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)
por: Schildgen, Verena, et al.
Publicado: (2022)

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine
por: Hussein, Nawfal R., et al.
Publicado: (2022)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections
por: Fan, Qinghong, et al.
Publicado: (2022)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York
por: Duerr, Ralf, et al.
Publicado: (2022)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
por: Lechmere, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rkvdvis0a01pahvecegvhhmjji